Oliver Dolan Biography and Net Worth

SVP of Korro Bio

Oliver Dolan is the SVP of Korro Bio. They are 43 years old.

What is Oliver Dolan's net worth?: The estimated net worth of Oliver Dolan is at least $225.43 thousand as of September 11th, 2026. Dolan owns 16,241 shares of Korro Bio stock worth more than $225,425 as of September 14th. This net worth estimate does not reflect any other investments that Dolan may own. Learn More about Oliver Dolan's net worth.
How do I contact Oliver Dolan?: The corporate mailing address for Dolan and other Korro Bio executives is 75 HAYDEN AVENUE SUITE 300, LEXINGTON MA, 02421. Korro Bio can also be reached via phone at 781-315-4600 and via email at [email protected]. Learn More on Oliver Dolan's contact information.
Has Oliver Dolan been buying or selling shares of Korro Bio?: During the last quarter, Oliver Dolan has sold $99,408.17 in shares of Korro Bio stock. Most recently, Oliver Dolan sold 5 shares of the business's stock in a transaction on Friday, September 11th. The shares were sold at an average price of $13.72, for a transaction totalling $68.60. Following the completion of the sale, the senior vice president now directly owns 16,241 shares of the company's stock, valued at $222,826.52. Learn More on Oliver Dolan's trading history.
Who are Korro Bio's active insiders?: Korro Bio's insider roster includes Ram Aiyar (Chief Executive Officer & President), Todd Chappell (Chief Operating Officer), Oliver Dolan (SVP), Jean Formela (Director), and Loïc Vincent (Chief Scientific Officer). Learn More on Korro Bio's active insiders.
Are insiders buying or selling shares of Korro Bio?: During the last twelve months, Korro Bio insiders bought shares 11 times. They purchased a total of 1,664,004 shares worth more than $18,491,374.58. During the last twelve months, insiders at the sold shares 15 times. They sold a total of 344,295 shares worth more than $4,841,701.20. The most recent insider tranaction occured on September, 11th when SVP Oliver Dolan sold 5 shares worth more than $68.60. Insiders at Korro Bio own 4.8% of the company. Learn More about insider trades at Korro Bio.
Information on this page was last updated on 9/11/2026.

Oliver Dolan Insider Trading History at Korro Bio

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2026	Sell	5	$13.72	$68.60	16,241
9/9/2026	Sell	6	$13.60	$81.60	16,246
9/8/2026	Sell	7,347	$13.51	$99,257.97	16,252

Oliver Dolan Buying and Selling Activity at Korro Bio

Korro Bio Company Overview

Korro Bio, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Today's Range

Now: $13.88

$13.56

$15.15

50 Day Range

MA: $12.62

$10.07

$14.72

2 Week Range

Now: $13.88

$5.20

$55.89

Volume

264,803 shs

Average Volume

188,254 shs

Market Capitalization

$204.40 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.09